Showing results (31-40 of 55) with videos related to
Sort By:
Pageof 6
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 16, 2018
Predictive validity of NEDA in the 16- and 21-year follow-up from the pivotal trial of interferon beta-1bDouglas S Goodin, Anthony T Reder, Anthony L Traboulsee, et al.Molecular and Cellular Biology|September 2, 2004
Integrin-linked kinase regulates endothelial cell survival and vascular developmentErik B Friedrich, Emerson Liu, Sumita Sinha, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|September 29, 2011
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trialDouglas S Goodin, Hans-Peter Hartung, Paul O'Connor, et al.JAMA Neurology|June 5, 2013
Interleukin 17F level and interferon β response in patients with multiple sclerosisHans-Peter Hartung, Lawrence Steinman, Douglas S Goodin, et al.Journal of Medical Internet Research|July 29, 2022
High-Resolution Digital Phenotypes From Consumer Wearables and Their Applications in Machine Learning of Cardiometabolic Risk Markers: Cohort StudyWeizhuang Zhou, Yu En Chan, Chuan Sheng Foo, et al.Journal of Neurology|August 5, 2015
Predictors of disease activity in 857 patients with MS treated with interferon beta-1bHans-Peter Hartung, Ludwig Kappos, Douglas S Goodin, et al.Clinical Science (London, England : 1979)|November 26, 2013
Detection of mutations in KLHL3 and CUL3 in families with FHHt (familial hyperkalaemic hypertension or Gordon's syndrome)Mark Glover, James S Ware, Amanda Henry, et al.Genome Research|May 6, 2014
Natural variation of histone modification and its impact on gene expression in the rat genomeCarola Rintisch, Matthias Heinig, Anja Bauerfeind, et al.JAMA Neurology|October 13, 2015
Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1bKathryn C Fitzgerald, Kassandra L Munger, Karl Köchert, et al.Journal of Neuroinflammation|June 19, 2012
Variability in detection and quantification of interferon β-1b-induced neutralizing antibodiesHans-Peter Hartung, Bernd Kieseier, Douglas S Goodin, et al.Pageof 6